Fundraising Fox

David Steinberg

Investor

General Partner at Longwood Fund

Massachusetts

Writes $100K – $5M checks Β· typically $1.5M

About

David Steinberg serves as Chief Business Development Officer at Formation Bio. He has co-founded five companies listed on the NASDAQ and has experience in venture capital, business development, and life science transactions.

Experience

  1. Formation BioChief Business Officercurrent2024 β€” presentNew York, New York, United States
  2. Carbon BiosciencesBoard Member, Founding CEO2022 β€” 2024Boston, Massachusetts, United States
  3. Photys TherapeuticsChairman, Founding CEO2021 β€” 2024Cambridge, Massachusetts, United States
  4. Rectify PharmaBoard Member2021 β€” 2024Boston, Massachusetts, United States
  5. Be BiopharmaChairman, Founding CEO2020 β€” 2024Cambridge, Massachusetts, United States
  6. Longwood FundGeneral Partner2019 β€” 2024Greater Boston Area
  7. Longwood FundVenture Partner2018 β€” 2019Greater Boston
  8. Lassen TherapeuticsBoard Member2020 β€” 2023
  9. Pyxis OncologyFounding CEO, former Chairman2019 β€” 2021Greater Boston
  10. resTORbioCo-Founder2017 β€” 2020Greater Boston
  11. Vor BiopharmaFounding CEO2016 β€” 2018Boston, Massachusetts
  12. Vedanta Biosciences, Inc.Founding CEO2011 β€” 2018Cambridge, MA
  13. PureTech HealthCo-Founder and Chief Innovation Officer2002 β€” 2018Greater Boston
  14. Enlight BiosciencesCEO2007 β€” 2011
  15. Boston Consulting GroupConsultant2001 β€” 2002
  16. Vertex PartnersConsultant1996 β€” 1999
  17. Procter & GambleResearch Associate1994 β€” 1996Norwich, NY

Education

  1. The University of Chicago Booth School of BusinessMBA, Strategy1999 β€” 2001
  2. Cornell UniversityBA, Biology1990 β€” 1994

Skills & more

Venture Capital31Start-ups46Life Sciences5Management Consulting13EntrepreneurEntrepreneurship33Biotechnology18Business Strategy10Lifesciences18Healthcare6Business Development15Product Launch13
+10 moreCommercializationMedical DevicesTechnology TransferR&DStrategyDrug DevelopmentProduct DevelopmentManagementMarketingDue Diligence

From David's professional profile.

Same school

Shared employers

Deals Β· 2

Carbon Biosciences, Inc.Board seat

via Longwood Fund Β· filed Jan 2022 Β· $38M raise

Pyxis OncologyBoard seat

via Longwood Fund Β· filed Mar 2021 Β· $172.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Longwood Fund

Network5

Investors connected to David in public investor directories β€” a warm-intro map.